$ANL News

Adlai Nortye H1 EPS $(0.04) Up From $(0.19) YoY, Sales $13.056M

Adlai Nortye Submits Clinical Trial Notification To Australia's TGA And Receives Approval From HREC To Commence Phase I Clinical Trial Evaluating AN4035 For Treatment Of CEACAM5-Enriched RAS-Addicted Solid Tumors

Adlai Nortye: AN9025 Still Needs Human Validation

Adlai Nortye Doses First Patient In The Intermittent Weekly Dosing Arm In Its Ongoing Phase 1 Clinical Trial Of AN9025, A Pan-RAS(ON) Inhibitor

Cantor Fitzgerald Initiates Coverage On Adlai Nortye with Overweight Rating

Oppenheimer Initiates Coverage On Adlai Nortye with Outperform Rating, Announces Price Target of $32

Jones Trading Initiates Coverage On Adlai Nortye with Buy Rating, Announces Price Target of $22

Are Medical Stocks Lagging ABCELLERA BIOLG (ABCL) This Year?

Here's Why Adlai Nortye Ltd. Sponsored ADR (ANL) Is a Great 'Buy the Bottom' Stock Now

H.C. Wainwright Sees “Potential Best-in-Class Potency” for Adlai Nortye’s (ANL) Lead Asset, Lifts PT

Adlai Nortye: Recapitalized, Refocused, But Still Too Early To Upgrade

Adlai Nortye (ANL): 10 Tiny Stocks That Are On Fire Right Now

Is ANI Pharmaceuticals (ANIP) Stock Outpacing Its Medical Peers This Year?

HC Wainwright & Co. Maintains Buy on Adlai Nortye, Raises Price Target to $20

Adlai Nortye Announces $150.0 Million Private Placement Equity Financing

Adlai Nortye shares are trading higher after the company announced it has entered into a $150 million securities purchase agreement for a private investment in public equity financing.

Adlai Nortye shares are trading higher after the company announced it has entered into a $150 million securities purchase agreement for a private investment in public equity financing.

Adlai Nortye Enters Into Securities Purchase Agreement For Private Investment In Public Equity Financing That Is Expected To Result In Gross Proceeds Of ~$150M

Is Astellas Pharma (ALPMY) Stock Outpacing Its Medical Peers This Year?

Adlai Nortye Ltd. Sponsored ADR (ANL) Upgraded to Buy: Here's Why